WuXi Biologics (Cayman)

(OTC) WXXWY

Current Price$8.55

Market Cap$17.69B

Since IPO (2017)+142%

5 Year-70%

1 Year+47%

1 Month-4%

WuXi Biologics (Cayman) Financials at a Glance

Market Cap

$17.69B

Revenue (TTM)

$40.25B

Net Income (TTM)

$8.22B

EPS (TTM)

$0.32

P/E Ratio

25.55

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$8.55

Volume

25,345

Open

$8.14

Price

$8.55

Volume

25,345

Open

$8.14

Previous Close

$8.55

Daily Range

$8.14 - $8.80

52-Week Range

$5.50 - $11.21

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$8.55

Volume

25,345

Open

$8.14

Previous Close

$8.55

Daily Range

$8.14 - $8.80

52-Week Range

$5.50 - $11.21

WXXWY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi Biologics (Cayman)

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

13,252

CEO

Zhi Sheng Chen, PhD

Website

www.wuxibiologics.com

Headquarters

Wuxi, 214092, CN

WXXWY Financials

Key Financial Metrics (TTM)

Gross Margin

46%

Operating Margin

30%

Net Income Margin

23%

Return on Equity

11%

Return on Capital

12%

Return on Assets

Earnings Yield

3.91%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.69B

Shares Outstanding

2.07B

Volume

25.34K

Avg. Volume

68.03K

Financials (TTM)

Gross Profit

$9.75B

Operating Income

$6.47B

EBITDA

$8.16B

Operating Cash Flow

$6.38B

Capital Expenditure

$3.58B

Free Cash Flow

$2.79B

Cash & ST Invst.

$15.75B

Total Debt

$3.11B

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$11.62B

+36.0%

Gross Profit

$5.66B

+73.2%

Gross Margin

48.71%

N/A

Market Cap

$17.69B

N/A

Market Cap/Employee

$1.41M

N/A

Employees

12,575

N/A

Net Income

$2.52B

+122.6%

EBITDA

$4.72B

+108.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$12.64B

+89.2%

Accounts Receivable

$8.90B

+43.9%

Inventory

$1.44B

-18.4%

Long Term Debt

$1.85B

-51.7%

Short Term Debt

$1.26B

+71.8%

Return on Assets

7.64%

N/A

Return on Invested Capital

11.88%

N/A

Free Cash Flow

$2.79B

+1174.1%

Operating Cash Flow

$4.59B

+96.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RXDXPrometheus Biosciences, Inc.

RXDXPrometheus Biosciences, Inc.$199.92+0.09%

NUVLNuvalent, Inc.

NUVLNuvalent, Inc.$99.04-1.24%

PRAXPraxis Precision Medicines, Inc.

PRAXPraxis Precision Medicines, Inc.$324.20+1.68%

RVMDRevolution Medicines, Inc.

RVMDRevolution Medicines, Inc.$139.48-3.22%

CORTCorcept Therapeutics Incorporated

CORTCorcept Therapeutics Incorporated$51.42+10.53%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$19.11-10.83%

EQRXEQRx, Inc.

EQRXEQRx, Inc.$2.34-2.09%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

AAPLApple

AAPLApple$280.14+0.03%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

TSLATesla

TSLATesla$390.82+0.02%

Questions About WXXWY

What is the current price of WuXi Biologics (Cayman)?

WuXi Biologics (Cayman) is trading at $8.55 per share.

What is the 52-week range for WuXi Biologics (Cayman)?

Over the past 52 weeks, WuXi Biologics (Cayman) has traded between $5.50 and $11.21.

How much debt does WuXi Biologics (Cayman) have?

As of the most recent reporting period, WuXi Biologics (Cayman) reported total debt of $444.19M.

How much cash does WuXi Biologics (Cayman) have on hand?

WuXi Biologics (Cayman) reported $1.32B in cash and cash equivalents in its most recent financial results.

What is WuXi Biologics (Cayman)’s dividend yield?

WuXi Biologics (Cayman) does not currently have a dividend yield.

WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Financials at a Glance

WXXWY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About WuXi Biologics (Cayman)

WXXWY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

WuXi Biologics (Cayman) Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About WXXWY

What is the current price of WuXi Biologics (Cayman)?

What is the 52-week range for WuXi Biologics (Cayman)?

How much debt does WuXi Biologics (Cayman) have?

How much cash does WuXi Biologics (Cayman) have on hand?

What is WuXi Biologics (Cayman)’s dividend yield?

Premium Investing Services